Advanced Oncologic Hyperthermia: Expert Medical Team
We bridge the gap between clinical oncology and biophysical engineering. Our certified medical team specializes in modulated RF hyperthermia (mHT) and Whole-Body Hyperthermia (WBH), integrating advanced thermal therapies with conventional protocols to enhance treatment efficacy.
Clinical Expertise in Deep Local Hyperthermia
Our multidisciplinary staff consists of oncology-focused physicians and biomedical engineers. By utilizing advanced modulated 13.56 MHz radiofrequency, we provide non-invasive interventions that selectively target malignant cells. Our protocols are designed based on strict clinical guidelines, ensuring that every patient receives validated thermal therapy.
Technology Independent Expertise: We are trained and certified to operate leading global systems including the HyDeep 600WM (advanced oncological hyperthermia system), Oncotherm, Heckel, and Von Ardenne.
Accreditations from the German Society for Hyperthermia (DGHT)
Our medical team is personally trained and certified under the rigorous standards of the DGHT, ensuring the highest safety protocols in oncological thermotherapy.
Advanced clinical training session with Dr. med. Husein Sahinbas (President of DGHT).
Leading the Romanian Society of Oncologic Hyperthermia (SRHO)
Our clinical authority is reinforced by our roles as founders of the Romanian Society of Oncologic Hyperthermia (SRHO). Under the guidance of M.Sc. Cristian Gologan and Dr. med. Veronica Iatan, SRHO works to integrate thermal medicine into standardized clinical oncology protocols in Romania.
Active collaboration with ESHO (European Society for Hyperthermic Oncology).
Alignment with protocols from DGHT eV (German Society for Hyperthermia).
Active collaboration with SIIO (Italian Society for Oncological Hyperthermia).
State-of-the-Art Medical Technology
To deliver exceptional patient care, our medical team utilizes advanced electromedical equipment from leading global manufacturers. Among these technologies is the HyDeep 600WM, produced by Andromedic Srl. This MDR-certified mHT system functions as a high-precision deep local hyperthermia device, capable of penetrating up to 38.4 cm to target visceral tumors with modulated RF energy.
FAQ: Clinical Hyperthermia
How does Modulated RF Hyperthermia (mHT) enhance cancer treatment?
mHT utilizes 13.56 MHz radiofrequency to heat the tumor microenvironment (39°C-43°C). This increases blood perfusion and oxygenation, rendering cancer cells significantly more susceptible to radiotherapy and chemotherapy.
Is hyperthermia safe for all cancer patients?
Hyperthermia is generally safe and non-invasive. Our certified physicians perform a thorough medical screening to ensure patient eligibility, especially concerning metallic implants or cardiovascular conditions.
Consult with our Clinical Specialists
Gain access to advanced thermal protocols and technical support.